Gan & Lee Pharmaceuticals

Established in 1998, Gan & Lee Pharmaceuticals is an advanced biopharmaceutical company specialized in the exploration, formulation, manufacturing, and marketing of insulin and its derivatives, holding a prominent position in the diabetes sector in China. Since its establishment, Gan & Lee has directed its efforts toward insulin synthesis. In 1998, Gan & Lee achieved a significant milestone by creating the initial domestically produced biosynthetic human insulin, a development acknowledged as one of China's top 10 scientific and technological advancements by the Chinese Academy of Sciences and Engineering. Up to now, Gan & Lee has introduced several comparable biosimilar insulin derivative products.

Products & Services

Basalin (Insulin Glargine Injection)

Ganlee Fine (Pen Injection Needle)

GanleePen (reusable insulin pen)

Insulin Aspart

Country

People's Republic of China

Show site details

Audit report available

Gan & Lee Pharmaceuticals

Country

People's Republic of China

City

Beijing

Insulin Glargine

Country

People's Republic of China

Show site details

Audit report available

Gan & Lee Pharmaceuticals

Country

People's Republic of China

City

Beijing

Sites